Samalizumab
Product Specifications
CAS Number
1073059-33-2
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9564
Bioactivity
Samalizumab (ALXN 6000) is a humanized anti-CD200 monoclonal antibody that specifically targets the CD200 immunoregulatory cell surface protein, a member of the immunoglobulin superfamily which functions to dampen excessive immune responses and maintain self-tolerance, thereby establishing Samalizumab as an effective immune checkpoint inhibitor currently under investigation for the treatment of myeloma and B-cell chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6181833-01 0.1 mL
PCGF2 (polycomb Group Ring Finger 2, MEL-18, MGC10545, RNF110, ZNF144) (HRP)
Sign In for Pricing
View Details 
MBS6181833-02 5x 0.1 mL
PCGF2 (polycomb Group Ring Finger 2, MEL-18, MGC10545, RNF110, ZNF144) (HRP)
Sign In for Pricing
View Details GTR15087380 1 Vial
Lentiviral human APOC1 shRNA (UAS) - Lentiviral human APOC1 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details MBS6381873-01 0.1 mL
HSPBP1 (HSPBP, Hsp70-binding Protein 1, Heat Shock Protein-binding Protein 1, Hsp70-binding Protein 2, Hsp70-interacting Protein 1, Hsp70-interacting Protein 2, HspBP2, PP1845, FES1) (FITC)
Sign In for Pricing
View Details 
MBS6381873-02 5x 0.1 mL
HSPBP1 (HSPBP, Hsp70-binding Protein 1, Heat Shock Protein-binding Protein 1, Hsp70-binding Protein 2, Hsp70-interacting Protein 1, Hsp70-interacting Protein 2, HspBP2, PP1845, FES1) (FITC)
Sign In for Pricing
View Details